Literature DB >> 23177662

Impact of geographic access to care on compliance and metabolic control in phenylketonuria.

Cynthia Freehauf1, Johan L K Van Hove, Dexiang Gao, Laurie Bernstein, Janet A Thomas.   

Abstract

OBJECTIVE: To study the impact of geographic access to care on metabolic control and compliance in phenylketonuria (PKU). STUDY
DESIGN: Phenylalanine (Phe) levels and number of samples obtained were abstracted from a data base of 76 patients age <21 years and compared for age, sex, and distance to clinic. Levels and number of samples were compared to the clinic guidelines for age.
RESULTS: There was a strong positive correlation between age and Phe levels in adolescents and young adults while age and number of samples submitted were negatively correlated. There was not a significant correlation between Phe levels and distance to clinic, nor was there a significant difference in the Phe levels by distant categories (Denver metro, Front Range, distant area). However, there was a decrease in number of samples sent compared to clinic guidelines by distance, with patients residing in distant areas (>100 miles) sending significantly less samples.
CONCLUSION: Geographic access to care does not impact control of Phe levels, but it does affect the number of monitoring samples sent to the clinic. Age groups of adolescents and young adults have a strong impact on both control of Phe levels and number of monitoring samples compared to clinic guidelines.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23177662     DOI: 10.1016/j.ymgme.2012.09.026

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  4 in total

1.  Demographic and Psychosocial Influences on Treatment Adherence for Children and Adolescents with PKU: A Systematic Review.

Authors:  Emma Medford; Dougal Julian Hare; Anja Wittkowski
Journal:  JIMD Rep       Date:  2017-08-25

2.  Effect of distance to health facility on the maintenance of INR therapeutic ranges in rheumatic heart disease patients from Cape Town: no evidence for an association.

Authors:  Dylan D Barth; Liesl J Zühlke; Alexia Joachim; Tyler Hoegger; Bongani M Mayosi; Mark E Engel
Journal:  BMC Health Serv Res       Date:  2015-06-05       Impact factor: 2.655

3.  Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.

Authors:  Maria Giżewska; Anita MacDonald; Amaya Bélanger-Quintana; Alberto Burlina; Maureen Cleary; Turgay Coşkun; François Feillet; Ania C Muntau; Friedrich K Trefz; Francjan J van Spronsen; Nenad Blau
Journal:  Eur J Pediatr       Date:  2015-09-08       Impact factor: 3.183

4.  The Impact of the First 2020 COVID-19 Lockdown on the Metabolic Control of Patients with Phenylketonuria.

Authors:  Dariusz Walkowiak; Bożena Mikołuć; Renata Mozrzymas; Łukasz Kałużny; Bożena Didycz; Joanna Jaglowska; Danuta Kurylak; Jarosław Walkowiak
Journal:  Nutrients       Date:  2021-06-12       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.